WE ARE THE DRIVING FORCE BEHIND CMT RESEARCH FOR A CURE.
WE ARE THE DRIVING FORCE BEHIND CMT RESEARCH FOR A CURE.
WE ARE THE DRIVING FORCE BEHIND CMT RESEARCH FOR A CURE.
WE ARE THE DRIVING FORCE BEHIND CMT RESEARCH FOR A CURE.
WE ARE THE DRIVING FORCE BEHIND CMT RESEARCH FOR A CURE.
When you participate in the Walk 4 CMT campaign, you fund patient programs and treatment research initiatives to better the lives of the the 2.8 million people living with CMT.
Acceleron recruited adults with CMT1 and CMTX for a Phase 2 clinical trial studying investigational drug ACE-083.
Thank you for your interest in participating, but the study is fully subscribed and registration is closed.
